In this episode, Joe interviews Mason Marks, MD, JD: drug policy analyst, writer, Professor at the Florida State University College of Law, and senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. As somewhat of an expert on drug […]
The post PT469 – Drug Policy in 2023: The FDA’s Guidance for Clinical Trials, The Natural Medicine Act, and SB-303 appeared first on Psychedelics Today.
